USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
02 Nov 2021 | 03:45 PM GMT

DTx last mile delivery - HCPs and patients adoption

Anchored by:

Shrawan Patel
Co-Founder & General Partner
PHARMSTARS

Participants:

Shrawan Patel Co-Founder & General PartnerPharmStars
Shrawan Patel
Co-Founder & General PartnerPharmStars
Anish Shindore Founder & Managing PartnerGSD Health
Anish Shindore
Founder & Managing PartnerGSD Health
Ary Deleray Digital Health Business LeaderRoche
Ary Deleray
Digital Health Business LeaderRoche
Christopher Hall Commercial Director, APACMarula Health
Christopher Hall
Commercial Director, APACMarula Health
Jim Howard CEOReadout Health
Jim Howard
CEOReadout Health
Jin Lee Director of Digital HealthAstellas Pharma, Inc
Jin Lee
Director of Digital HealthAstellas Pharma, Inc
JM
john mattison CMIOACP
JM
john mattison
CMIOACP
Kyloon Chuah Co-Founder, Chief Product & Tech OfficerVeriteos
Kyloon Chuah
Co-Founder, Chief Product & Tech OfficerVeriteos
Randy Horton VP of Solutions and PartnershipsOrthogonal
Randy Horton
VP of Solutions and PartnershipsOrthogonal
Ricardo C. Berrios Co-Founder & CEOAdhera Health, Inc.
Ricardo C. Berrios
Co-Founder & CEOAdhera Health, Inc.
Vasyl Pyrozhyk Vice PresidentSMBC
Vasyl Pyrozhyk
Vice PresidentSMBC

About this Meeting

While the DTx market is growing exponentially, the scale of usage from the physician and patient cohorts remains low.  Despite proven clinical outcomes, regulatory approvals, usage and spread remains slim. For example, even though German DiGA has 20 approved products so far, their prescription and adoption have not taken off yet. Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx; we will talk about: 

  •  How do we make HCPs aware of DTx solutions? Should we use the same model used for drugs, or what are the alternatives? 
  •  DTx integration into physicians’ tools (like EMR, CDSS, etc) and workflow so that they are able to prescribe/recommend a DTx - Challenges and best practices
  •  How do we ensure the proper onboarding for DTx products? Does the physician need to know how to do the patient onboarding? Is it a pharmacist job, is it patients, is it developers? 
  •  Why would physicians want to prescribe/recommend a DTx product? What are their motivations? Is being reimbursed a must so that a physician wants to recommend/prescribe a product?